Your physician can assess whether the benefits of continuing the weight loss injection outweigh the gastrointestinal burden
TL;DR GLP-1 drugs such as semaglutide, tirzepatide, and liraglutide can help reduce appetite and body weight, but emerging research shows they may also increase the risk of protein, vitamin, and mineral deficiencies, especially when appetite drops sharply and food intake becomes too low or too limited
They also slow down how quickly food leaves the stomach, which helps with weight loss
Semaglutide has demonstrated superior efficacy in glycemic control and weight loss compared to many other anti-diabetic drugs, earning it considerable recognition in the medical community
Though approximately 1.6% of Americans currently take some form of this medication, studies suggest that over 53% of the US population would be eligible for a semaglutide prescription
We at Biohackr Health administer semaglutide and tirzepatide, GLP 1 agonists which help with weight loss